🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Phenotypic Manifestations of Hereditary ATTR Amyloidosis

Recruitingn/aAges 20 Years - anyAllHospital 9 de Julio de Las Breñas
NCT07124377 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study focuses on hereditary transthyretin amyloidosis (ATTRv) with the Val50Met variant in a non endemic aerea

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * All subjects between 20 and 70 years of age, carriers of the Val50Met variant Exclusion Criteria: * Patients who refuse to participate.
💊

What it tests

  • A complete physical examination of all body systems, including height and body weight
  • Neurological examination includes motor strength testing; sensory testing with pinprick, light touch, temperature, and proprioception; deep tendon reflexes; and gait assessment.
  • Electrocardiogram (12-lead ECG)
  • 24-Hour Holter Monitoring
  • Color Doppler echocardiography with "two-dimensional strain" (longitudinal strain)
📍

Where

2 sites
Hospital las Breñas 9 de Julio
Charata, Argentina
Hosptial Las Breñas
Charata, Argentina
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy